ClinicalTrials.Veeva

Menu

Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures (JIIPROMS)

Smith & Nephew logo

Smith & Nephew

Status

Completed

Conditions

Journey II BCS Total Knee System

Treatments

Device: Total knee arthroplasty with Journey II BCS Total Knee System

Study type

Observational

Funder types

Industry

Identifiers

NCT03903731
16-4049-08B

Details and patient eligibility

About

Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.

Enrollment

600 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject received primary uni- or bi-lateral total knee arthroplasty with the Journey II BCS Total Knee System for approved indication;
  • The TKA occurred at least 12 weeks prior to enrollment
  • Subject records contain Patient Reported Outcome data obtained ≤3 months prior to as well as ≥6 months post-enrollment.

Exclusion criteria

  • Subject received the JOURNEY II BCS Total Knee System on the affected knee as a revision for a previously failed total or unicondylar knee arthroplasty

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems